Wed, Apr 23, 2014, 11:21 AM EDT - U.S. Markets close in 4 hrs 39 mins

Recent

% | $
Quotes you view appear here for quick access.

Quest Diagnostics Inc. Message Board

  • ameritrader01 ameritrader01 Feb 16, 2013 9:21 AM Flag

    DGX and Umass acquisition is a very Big Deal:

    When the decision was made to acquire Umass Laboratory, it was done so realizing this new landscape of healthcare we will be about to be thrust into...BUT not for UMASS, which has been a part of this idealism since Governor Romney instituted it when he was in office. How another Laboratory didn't look at this as a "no brainer" way to acquire the model for which all healthcare will follow is beyond me. Also, realizing the control Umass has on the healthcare/Laboratory system in the New England is astonishing,(Do your homework and research you will be surprised). I feel Quest has acquired the Platinum Egg with this acquisition, especially realizing the size, scope and relatively "cheap" and non-challenged entry into this new platform being a significant edge on the competition which will be realized once Obamacare becomes the norm and we begin to buy our health insurance similarly to how we shop in a supermarket by brands and necessity. My only concern here is that although the Umass acquisition will be the benchmark for all others in the medical laboratory sector. Also, do not forget CT, home of the Gold Coast where "Cash Rich" Quest Diagnostics has a large presence, it has been said that CT will be one of the states which will see some of the best levels of healthcare upon the move to Obamacare due to decisions which are being made at State level to support a higher and more affordable level of healthcare coverage which would be expected of insurance companies that would be selling their plans in the state.

 
DGX
58.65+0.25(+0.43%)11:20 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.